Cargando…
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Therapeutic options for patients with amyotrophic lateral sclerosis (ALS) are currently limited. However, recent studies show that almost all cases of ALS, as well as tau-negative frontotemporal dementia (FTD), share a common neuropathology characterized by the deposition of TAR-DNA binding protein...
Autores principales: | Scotter, Emma L., Chen, Han-Jou, Shaw, Christopher E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404432/ https://www.ncbi.nlm.nih.gov/pubmed/25652699 http://dx.doi.org/10.1007/s13311-015-0338-x |
Ejemplares similares
-
Mechanisms of TDP-43 Proteinopathy Onset and Propagation
por: Chen, Han-Jou, et al.
Publicado: (2021) -
Mechanisms and models of TDP-43 proteinopathies
por: Petrucelli, Leonard
Publicado: (2012) -
Rodent Models of TDP-43 Proteinopathy: Investigating the Mechanisms of TDP-43-Mediated Neurodegeneration
por: Gendron, Tania F., et al.
Publicado: (2011) -
Molecular Neuropathology of TDP-43 Proteinopathies
por: Neumann, Manuela
Publicado: (2009) -
Drosophila Answers to TDP-43 Proteinopathies
por: Romano, Maurizio, et al.
Publicado: (2012)